Skip to main content
Defiance International

Quality literacy / Foundation

Research-use limits are substantive, not marketing language

How research-use restrictions, manufacturing claims, IVD-specific RUO vocabulary, documentation, and custody evidence should be read without treating a model as a legal conclusion.

Course overview

A guide to Research Use Only (RUO) labeling, FDA regulatory jurisdiction, the intended use doctrine, and GLP compliance.

Track
Quality literacy
Level
Foundation
Lessons
10
Estimated duration
50 min

Complete course curriculum (10 lessons)

  1. Lesson 1

    Regulatory Categories: RUO vs IND vs Approved Pharmaceutical

    Learning objective:
    Understand legal boundaries between research materials, investigational articles under an IND, and approved pharmaceuticals.
    Core mechanism:
    Research Use Only (RUO) products are chemical substances intended exclusively for laboratory research, in vitro diagnostic development, or non-clinical assays. They are not approved for human or veterinary use.
    Key takeaway:
    An RUO label describes a permitted research use; it does not by itself exempt a material from regulation, and it never permits marketing for human administration.

  2. Lesson 2

    The FD&C Act Framework

    Learning objective:
    Examine how the FD&C Act defines a regulated article by its intended diagnostic, therapeutic, or structural effect.
    Core mechanism:
    Any article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, or intended to affect the structure or function of the body, falls inside the statutory category the FD&C Act defines.
    Key takeaway:
    Commercial claims regarding bodily effects can bring an article inside that statutory classification under federal law.

  3. Lesson 3

    RUO Labeling Invariants & Mandatory Boundary Statements

    Learning objective:
    Analyze required container labeling, prominent disclaimer text, and prohibited claims.
    Core mechanism:
    RUO products must prominently display: “For Research Use Only. Not for Human or Animal Use.” Labels cannot contain dosing, reconstitution protocols for injection, or therapeutic indications.
    Key takeaway:
    Proper RUO labeling requires explicit disclaimers and complete absence of clinical administration guidance.

  4. Lesson 4

    The Intended Use Doctrine

    Learning objective:
    Examine how the FDA establishes objective intent through marketing, communications, and customer interactions.
    Core mechanism:
    Objective intent is determined by the totality of circumstances: advertising claims, social media, customer support advice, packaging, and commercial relationships.
    Key takeaway:
    Providing dosing advice or therapeutic instructions can establish an intended use inside that statutory category, whatever the label says.

  5. Lesson 5

    Good Laboratory Practices (GLP / 21 CFR Part 58)

    Learning objective:
    Understand GLP quality systems for non-clinical laboratory safety studies.
    Core mechanism:
    GLP governs laboratory facilities, equipment calibration, standard operating procedures (SOPs), test article characterization, study directors, and Quality Assurance Units (QAU).
    Key takeaway:
    GLP ensures data integrity, traceability, and reproducibility in non-clinical safety research.

  6. Lesson 6

    Institutional Oversight: IACUC & Biosafety Committees

    Learning objective:
    Examine ethical and safety governance for laboratory animal research and recombinant DNA.
    Core mechanism:
    Institutional Animal Care and Use Committees (IACUC) review animal research protocols. Institutional Biosafety Committees (IBC) oversee recombinant DNA and biological agents.
    Key takeaway:
    Non-clinical animal research requires formal institutional ethical review and protocol pre-approval.

  7. Lesson 7

    Chemical Safety & Safety Data Sheet (SDS) Literacy

    Learning objective:
    Read 16-section OSHA GHS Safety Data Sheets for hazardous chemical handling.
    Core mechanism:
    SDS documents declare chemical hazard classifications, signal words (Danger/Warning), pictograms, PPE requirements, exposure limits, toxicology, and emergency spill procedures.
    Key takeaway:
    Reviewing the chemical SDS is mandatory prior to handling any synthetic research material in the laboratory.

  8. Lesson 8

    Chain of Custody & Material Transfer Agreements (MTAs)

    Learning objective:
    Understand legal contracts governing the transfer and permissible use of research materials.
    Core mechanism:
    MTAs govern ownership, intellectual property, confidentiality, publication rights, and liability when transferring proprietary chemical sequences or biological materials between institutions.
    Key takeaway:
    MTAs establish binding legal boundaries on how research materials and derived data may be utilized.

  9. Lesson 9

    Gray Market Pitfalls: Adulteration & Misbranding Risks

    Learning objective:
    Analyze the legal and safety consequences of illicit grey-market chemical sequence sales.
    Core mechanism:
    Selling research chemicals with implied or explicit human use instructions can constitute misbranding and adulteration under the FD&C Act.
    Key takeaway:
    Suppliers offering “research chemicals” alongside dosing guides operate in direct violation of the federal misbranding and adulteration statutes.

  10. Lesson 10

    Capstone Compliance Audit: Maintaining Lawful Non-Clinical Operations

    Learning objective:
    Conduct a comprehensive regulatory compliance review of laboratory research practices.
    Core mechanism:
    Synthesizes statutory definitions, labeling checks, objective intent auditing, GLP documentation, and SDS controls into a robust compliance framework.
    Key takeaway:
    Uncompromising compliance with RUO boundaries protects scientific integrity and ensures lawful laboratory operations.

Claim boundary

Research use only describes the permitted use of our materials; it is not a general exemption from regulation. Requirements depend on the actual article, intended use, representations, distribution and activity. Research chemicals, investigational drugs, devices and in vitro diagnostic products can fall under different rules. A disclaimer, professional credential or research approval does not establish a product's classification or satisfy every applicable obligation. Defiance materials are supplied solely for lawful in vitro laboratory research and must not be administered to humans or animals or used for clinical diagnosis.